LR Health & Beauty SE, NO0013149658

LR Health & Beauty SE / NO0013149658

14.11.2025 - 15:46:53

LR Health & Beauty SE initiates a Written Procedure under its outstanding 2024/2028 Bonds 

LR Health & Beauty SE / Key word(s): Bond
LR Health & Beauty SE initiates a Written Procedure under its outstanding 2024/2028 Bonds 

14.11.2025 / 15:46 CET/CEST
The issuer is solely responsible for the content of this announcement.


LR Health & Beauty SE initiates a Written Procedure under its outstanding 2024/2028 Bonds  Ahlen, 14 November 2025 – LR Health & Beauty SE (the “Company”) announced on 20 October 2025 that the board of the Company identified an expected breach of the leverage covenant requiring the Company to maintain a ratio of net debt to EBITDA of 4.50:1 as at 30 September 2025 (the “Leverage Covenant”) under the terms and conditions (the “Terms and Conditions”) of the 2024/2028 bonds (ISIN: NO0013149658) (the “Bonds”).  Today, the board of the Company decided to initiate a written procedure (the “Written Procedure”) among the holders of the Bonds (the “Bondholders”) in accordance with the Terms and Conditions. For the period up to and including 28 February 2026, the Bondholders shall consent to temporarily waive any breach and/or event of default resulting from any (i) non-compliance with the maintenance test (including any potential breach of the Leverage Covenant), and (ii) postponement of interest payments under the Bonds due in November 2025 and February 2026 until such later date as will be set out in a restructuring proposal, provided that such date is approved by the Bondholders. A notice of the Written Procedure, including voting instructions, has today been sent by the agent under the Terms and Conditions to the direct registered owners and registered authorised nominees of the Bonds. The last day for voting in the Written Procedure is 28 November 2025 and the voting record date is 17 November 2025. The Written Procedure may however be terminated before the expiry of the time period for replies if a requisite majority has been obtained. The notice of the Written Procedure and further details are accessible on the Company’s website at https://ir.lrworld.com/en/bond/.


LR Group Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence. The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe. In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report. LR currently has around 1,200 employees and hundreds of thousands of registered community members.


Contact: PR Contact: LR Health & Beauty SE 
Almut Kellermeyer  
Head of Corporate Communication  
Kruppstraße 55 
59227 Ahlen 
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/   IR Contact: cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de


14.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
Language: English
Company: LR Health & Beauty SE
Kruppstr. 55
59227 Ahlen
Germany
Phone: +49 238270600
E-mail: info@lrworld.com
Internet: www.lrworld.com
ISIN: NO0013149658
WKN: A3H3FM
Listed: Regulated Unofficial Market in Frankfurt; Stockholm
EQS News ID: 2230306

 
End of News EQS News Service

2230306  14.11.2025 CET/CEST
@ dgap.de